Background {#Sec1}
==========

In recent decades, American Indian/Alaska Native (AI/AN) communities have experienced rising rates of cardiovascular disease \[[@CR1]\], with a prevalence of cardiovascular disease among AI/AN nearly two-fold higher than the overall US population \[[@CR2]\]. Rates of diabetes mellitus (DM) have also dramatically increased over the past few decades in many AI/AN communities. Mortality due to diabetes is 2.5 to 3.5 times higher among AI/AN populations than the United States mortality rate across all races \[[@CR3]\]. The cost of diabetes care is also considerable; O'Connell, et al., estimated that diabetes care accounted for 37% of all adult treatment expenses in one Indian Health Service (IHS) facility \[[@CR4]\].

The Navajo Nation experiences numerous challenges to improving cardiovascular disease care. Many patients living on the Navajo reservation struggle with chronic disease management due to access barriers to regular healthcare services. Primary care services are challenged by chronic understaffing of healthcare professionals and limited resources \[[@CR5]\]. Extreme geographic distances and lack of transportation make appointment attendance and medication refills difficult. Furthermore, patients face barriers to cross-cultural communication with their IHS providers \[[@CR5]\]. Health education is often suboptimal due to a lack of patient educational materials appropriate to AI/AN populations \[[@CR6]\].

There is growing advocacy for integrating community health workers (CHWs) within the U.S. healthcare delivery system \[[@CR7]\]. The Patient Protection and Affordable Care Act identifies community health workers as an important part of the care team for delivery system reform and authorizes funding for CHWs in medically underserved communities \[[@CR8]\]. The Institute of Medicine has recommended that CHWs should be integrated into multidisciplinary teams as an approach to eliminate health disparities \[[@CR7], [@CR9]\], and the Centers for Disease Control and Prevention has recommended integral inclusion of CHWs for diabetes management \[[@CR10]\]. Similarly, the Agency for Healthcare Research and Quality conducted a systematic review of CHW interventions and found that community health workers can improve health outcomes among underserved populations; however, they noted that methodological limitations of many of the studies limited the ability to draw strong conclusions across a variety of clinical conditions \[[@CR11]\]. Overall, there is growing momentum to incorporate CHWs as integral members of the care team particularly when caring for underserved populations, which requires community outreach and cultural competency \[[@CR12]\]. To better address workforce shortages and create patient-centered medical homes \[[@CR8]\], there is an urgent need for data regarding the impact of robust, real-world models of CHWs when they are integrated into the clinic team and function at the top of their skill set.

The Community Outreach and Patient Empowerment (COPE) intervention seeks to address health disparities in AI/AN communities by strengthening the role of CHWs and building stronger linkages between community and clinic-based providers. COPE activities focus on building synergy between IHS quality improvement activities and the Navajo Nation Community Health Representative (CHR) Program within a socio-ecological framework \[[@CR13], [@CR14]\]. CHRs are tribal CHWs and have a long history in tribal healthcare systems. For the purposes of this manuscript, the term CHW refers to the broader healthcare profession which includes CHRs. By strengthening coordination and collaboration among inter-professional teams involving IHS providers and CHRs, COPE reaches out to high-risk patients with uncontrolled cardiovascular disease risk factors to promote healthy lifestyles, facilitate access to the healthcare delivery system, and enhance self-efficacy of patients, family members and CHRs themselves. The intervention expands the role of CHRs by providing skills, knowledge, and networks to deliver effective support to high-risk individuals.

We have studied the effectiveness of the COPE intervention and found it improves glycosylated hemoglobin (HbA1c) control for diabetic patients \[[@CR15]\]. In this paper, we examine the impact of the COPE program on healthcare utilization by individuals living with diabetes on Navajo Nation. We hypothesized that the intervention would result a greater increase in healthcare utilization compared with control patients, without an increase in hospitalization or emergency department services.

Methods {#Sec2}
=======

Study setting and population {#Sec3}
----------------------------

This observational cohort study took place in Navajo Nation from 2010 through 2014. Navajo Nation has 332,129 members and covers 27,000 mile^2^ in parts of Arizona, Utah, and New Mexico \[[@CR16]\]. The Navajo Area Indian Health Service (NAIHS) is one of 12 regional administrative units of the national IHS system. The NAIHS is divided into eight sub-regional "Service Units", comprised of a total of 6 hospitals, 7 health centers, and 15 health stations. Separate from Indian Health Services, the tribe oversees its own health programs under the auspices of the Navajo Nation Department of Health, including the Navajo CHR Program. Formally established in 1968, the Navajo CHR Program includes nearly 100 CHRs who offer crucial services for patients and families including health education and in-home health assessments. Each Service Unit has between six and 18 CHRs, each of whom is assigned to specific communities, called Chapters.

Program intervention {#Sec4}
--------------------

COPE was started in 2010 as collaboration between the Navajo CHR Program, Brigham and Women's Hospital, and the NAIHS. This program has been implemented in all eight Service Units of the Navajo Area, and more than 650 patients have been enrolled to date. The "COPE intervention" is comprised of three inter-related strategies designed to strengthen existing community outreach and linkage to clinic-based care. The intervention focuses on three activities: 1) training CHRs to ensure proficiency in health topics and build skills in behavior change techniques such as motivational interviewing and goal-setting; 2) developing patient coaching materials that CHRs can then use in the home; and 3) facilitating greater connection and communication between the patient and clinic-based team. Centers for Disease Control and Prevention recommendations for strengthening the role of CHWs include 1) clear definitions regarding the scope of activities, 2) rigorous training standards, 3) increased clinician awareness about the role of CHWs, and 4) enhanced professional support networks for CHWs \[[@CR17]\]. COPE addresses all of these recommendations through standardized CHR training, close supervision, quality control of CHR activities, and integration of CHR activities into the primary care teams in IHS facilities.

Participant selection {#Sec5}
---------------------

Although individuals living with any chronic condition may enroll in COPE, the vast majority have Type 2 diabetes mellitus, and, as described above, diabetes is a serious chronic health condition prevalent in Navajo Nation. Therefore, our prospective cohort study of COPE enrollees included COPE enrollees who: (1) have been diagnosed with diabetes, (2) received care in one of the participating Service Units, and (3) had at least one baseline measure of HbA1c prior to enrolling in COPE. The study encompassed six of the eight Service Units in Navajo Nation that had implemented COPE; we excluded two Service Units because of low COPE enrollment at one site, and use of a different electronic health record system at the other. We abstracted data for adults with an ICD-10 diagnosis of diabetes mellitus from the IHS resource and patient management system (RPMS). RPMS is an electronic health record that is used by the majority of IHS facilities for routine clinical care; each facility maintains an individual RPMS database with administrative and clinical data \[[@CR18]\]. In addition to clinical diagnoses, we abstracted laboratory tests, vital signs, medications, and healthcare utilization data from RPMS.

A matching algorithm was generated to identify patients seen at multiple sites and to identify COPE patients within the database. Once patients were identified across sites and COPE cases were captured, the dataset was de-identified. Within this dataset, we matched COPE participants to non-COPE patients based on age (+/− 5 years), gender, primary health facility, hemoglobin HbA1c (+/− 1 point) and systolic blood pressure (+/− 10 mmHg) at baseline (i.e. 3 months prior to the date of COPE enrollment). The matching process is presented in detail in Trevisi et al. \[[@CR17]\]

Study outcomes and confounding factors {#Sec6}
--------------------------------------

Our primary study outcome was the frequency with which patients are hospitalized, visit outpatient clinics, or otherwise use healthcare resources. IHS service unit utilization is primarily organized around clinics, and each healthcare encounter in RPMS lists the clinic visited by the patient. We used the RPMS clinic variable as the basis for the frequency of utilization analysis. With approximately 120 types of "encounters" (because "clinic" may also include miscellaneous types of utilization that are not, strictly speaking, a clinic visit, such as telephone call, chart review, and outpatient use of an inpatient treatment room, for example, we chose to use the broader term "type of encounter"), we grouped utilization into seven broad categories: community encounters, counseling/behavioral, dental, emergency, inpatient, primary care, and specialty care. Of note, community encounters included other community-based services -- such as public health nurse visits and school visits -- but did not include CHR visits.

Each type of encounter reported in RPMS was counted as one utilization incident for the purposes of this analysis. For inpatient services, the primary data point was the presence of a DRG code indicating the patient was hospitalized. However, we also included encounter listings for labor and delivery and for observation as inpatient utilization. Table [1](#Tab1){ref-type="table"} presents the encounters listed and their grouping for the purposes of the utilization analysis. We excluded from the analysis utilization such as telephone calls and telemedicine because the frequency with which these were reported suggested they were inconsistently recorded. Chart review was also excluded because it did not represent a separate, distinct encounter for the patient. Table 1Types of Encounters as Reported in RPMS and Categorization for Utilization AnalysisCategory for AnalysisCategory for Analysis Reported Encounter Type \[a\] Reported Encounter Type**Community encountersSpecialty outpatient (cont.)**  Home Care  Chronic Disease  School  Colposcopy**Counseling/behavior**  Complementary Medicine  Alcohol and Substance  Day Surgery  Behavioral Health  Dermatology  Day Treatment  Diabetic (including Footcare and Retinopathy)  Diabetes Education  Dialysis  Education Classes  Dietary  General Preventive  Endocrinology  Group Services  ENT  Medical Social Services  Family Planning  Mental Health  High Risk  Telebehavioral Health  Medication Therapy Management  Tobacco Cessation Clinic  Nephrology  Wellness  Neurology** Dental**  Obesity**Emergency**  Ob/Gyn  Emergency Medicine  Ophthalmology  Triage  Optometry  Urgent Care  Orthopedic**Inpatient**  Pain Management  Labor and Delivery  Physical Therapy/Occupational Therapy  Observation  Plastic Surgery  Hospitalization (if DRG listed) \[b\]  Podiatry**Primary Care Outpatient**  Postpartum  Elder Care  Pulmonology  Family Practice  Radiation Exposure Screening  General  Rehabilitation  Immunization  Respiratory Care  Internal Medicine  Rheumatology  Pediatric  Speech Pathology/Speech Therapy  Well Child  Sports Medicine**Specialty Care Outpatient**  STD  Anesthesiology  Surgical  Anticoagulation Therapy  Teen Clinic  Audiology  Traditional Medicine  Cancer Screening  Urology  Cardiology  Women's Health Screening  Chest and TB  Wound Care\[a\] For the purposes of this table, some clinics reported as separate in RPMS have been combined for brevity (e.g. Physical Therapy/Occupational Therapy)\[b\] Visits are also categorized as inpatient if no clinic is reported but a DRG is reported

A second outcome was the utilization of lab and radiology services by counting the individual number of lab or radiology tests ordered, identified using Current Procedural Terminology (CPT) codes. The use of pharmacy services was measured using the number of medications prescribed.

Our outcomes of interest were the total number healthcare utilizations by type of encounter and intervention group in each quarter. We also aggregated over encounter types to measure the frequency of total healthcare clinic utilization for each patient, but excluding lab, radiology, and pharmacy utilization.

Community participation and ethical considerations {#Sec7}
--------------------------------------------------

Our study protocols were developed and interpreted collaboratively with two stakeholder groups. The COPE Advisory Group established in 2012 is comprised of local physicians, nurses, program leaders, information technology specialists, Navajo Nation Department of Health program directors, and CHR supervisors and the Community Health Advisory Panel (CHAP), established in 2013, which includes COPE participants, their relatives, and CHRs. The COPE Advisory Group and Community Health Advisory Panel meet quarterly and provided suggestions on how to group health services, ensuring that study findings could be disseminated in a comprehensible manner to patients and families, and providing interpretive feedback on results.

For this study, Community Health Advisory Panel participants requested additional data on utilization of traditional medicine services. We shared that visits to Traditional Medicine services were included as Specialty Outpatient care and accounted for 476 of 82,803 (0.57%) of Specialty Outpatient visits. COPE Advisory Group members suggested a sensitivity analysis excluding community encounters (e.g. joint home visits between public health nurses and CHRs), in case CHRs visits may have been included in this group.

This study was approved by Partners Healthcare Institutional Review Board (2012P001069) and the Navajo Nation Human Research Review Board (NNR-11.150 T). In order to abstract data, study staff obtained necessary certification and training required by the Indian Health Services Rules of Behavior under the auspices of Collaborative Agreements with participating sites (NV-CA-10-0011, NA-CA-13-0013, NA-CA-11-0062).

Statistical approach {#Sec8}
--------------------

We used a generalized linear mixed regression model for count outcomes, assuming a Poisson distribution for the outcome variable using a log-link to assess the differences in the frequency of healthcare utilization between COPE and non-COPE patients. The analysis was implemented with the SAS PROC GLIMMIX, and performed using SAS 9.3 (SAS Institute, Cary, North Carolina).

We used random effects to account for patient correlation over time, and within-site correlation at the service unit. We also adjusted for covariates with potential influences on utilization that exist at the time of the intervention: age, gender, language, primary care physician, and the following diagnoses: essential hypertension, major depression disorder, alcohol abuse, major cardiovascular disease (defined as at least one of the following diagnoses: acute myocardial infarction, coronary artery bypass surgery, coronary angioplasty, peripheral arterial disease, abdominal aortic aneurysm, carotid artery disease, cerebrovascular disease), and dyslipidemia.

In the model, we measured the outcome of interest as the number of encounters by encounter type that each participant had in each period, as well as the covariates listed above to adjust for differences between patients. The regression model measured the change (or trend) in utilization over time distinguishing the pre-intervention trend from the post-intervention trend, and utilization by COPE patients versus non-COPE patients. The model was parameterized so that the regression coefficients for utilization directly measure the difference in COPE patient utilization relative to non-COPE patients both before and after enrollment in COPE. Thus, we were most concerned with the value and statistical significance of the regression coefficient that measured the difference in utilization trend between the control group and the COPE group following the intervention. First, if it did not differ significantly from the post-intervention utilization trend of the control group, then statistically there was no difference between any post-intervention change that might have occurred to the control group and the COPE group. Even if a change occurred in the utilization trend, because the control group did not experience the COPE intervention, we could not attribute whatever change occurred in the COPE group to the COPE intervention. Second, if the COPE post-intervention coefficient was statistically significant and greater than zero, COPE patient utilization of health resources would have increased relative to control group patients; if it was statistically significant and less than zero, COPE patient utilization of health resources would have decreased relative to the control group. The model is presented in further detail in the [technical appendix](#MOESM1){ref-type="media"}.

Results {#Sec9}
=======

The study covered 17 quarters of healthcare utilization: 2 years (8 quarters) of utilization prior to the intervention, the quarter in which the patient enrolled in COPE, and 2 years following the intervention. Among the 28,813 adult patients with an ICD-10 diagnosis of DM in the database, a total of 173 COPE patients met study inclusion criteria, and were matched to 2880 control patients (10.1% of all non-COPE patients) comprising the cohort for evaluating healthcare utilization, the same cohort that was used to evaluate clinical endpoints \[[@CR15]\].

Table [2](#Tab2){ref-type="table"} presents the baseline characteristics of the COPE and non-COPE cohorts. The majority of patients were between 56 and 85 years of age, and approximately two-thirds of both the COPE intervention and control groups were female. Almost 58% of COPE clients reported as primary language their Native language and not English, compared with 40.9% of the matched controls. The majority of individuals had both essential hypertension (65.3% among COPE clients, 68.3% among controls) and major cardiovascular disease (approximately 71% for both COPE clients and controls). In contrast, the reported prevalence of mental health disorders were low: depression was documented among 14.5 and 9.8% among COPE patients and controls, while alcohol use disorders were observed among 6.4% versus 2.7% of COPE versus control patients, respectively. Table 2Baseline Characteristics of Study Cohort \[a\]COPE *N* = 173NON-COPE *N* = 2880**Patient CharacteristicN (%)N (%)Age** 25--40 y7 (4.1)46 (1.6) 41--55 y33 (19.1)610 (21.2) 56--70 y74 (42.8)1436 (49.9) 71--85 y54 (31.2)764 (26.5)  ≥ 86 y5 (2.9)24 (0.8)**Gender** Male65 (37.6)901 (31.3) Female108 (62.4)1979 (68.7)**Primary Language** Native American100 (57.8)1178 (40.9) English72 (41.6)1700 (59.0) Missing1 (0.6)2 (0.1)**Primary Care Physician** Yes146 (84.4)2577 (89.5) No27 (15.6)303 (10.5)**Essential Hypertension** Yes113 (65.3)1966 (68.3) No60 (34.7)909 (31.6) Missing5 (0.2)**Major Depression Disorder** Yes25 (14.5)282 (9.8) No148 (85.6)2593 (90.0) Missing5 (0.2)**Alcohol abuse** Yes11 (6.4)77 (2.7) No162 (93.6)2798 (97.2) Missing5 (0.2)**Major Cardiovascular Disease** Yes123 (71.1)2050 (71.2) No50 (28.9)825 (28.7) Missing5 (0.2)**Dyslipidemia** Yes80 (46.2)1688 (58.6) No93 (53.8)1187 (41.2) Missing5 (0.2)\[a\] Characteristics evaluated at the closest available HbA1c measure before the enrollment date

Table [3](#Tab3){ref-type="table"} presents clinic utilization per patient per quarter (pppq) by type of encounter type and patient type. This demonstrates that, with the exception of dental care, the frequency of clinic utilization is consistently higher for COPE patients than for control patients both pre- and post-intervention. Table 3Healthcare Utilization by Type of Clinic Visited, Visits per Patient per Quarter, Pre- and Post-InterventionIntervention PatientsControl PatientsClinicN^1^MeanStandard Deviation95% CIN^1^MeanStandard Deviation95% CICommunity EncountersPre-1070.24660.3572(0.1789, 0.3142)4970.1220.3035(0.0953, 0.1486)Post860.71480.921(0.5202, 0.9095)4130.32860.69(0.2621, 0.3952)Counseling/ BehaviorPre-1330.20940.3824(0.1445, 0.2744)15480.10660.2535(0.094, 0.1192)Post1290.51260.7001(0.3918, 0.6335)15950.34940.5511(0.3223, 0.3764)DentalPre-690.10060.1555(0.0639, 0.1373)13940.13880.2204(0.1272, 0.1503)Post780.32860.4353(0.232, 0.4252)14170.45580.5582(0.4268, 0.4849)EmergencyPre-1400.29570.5083(0.2115, 0.3799)21600.22460.375(0.2088, 0.2404)Post1280.57960.7362(0.4521, 0.7072)21350.51480.5741(0.4905, 0.5392)InpatientPre-980.37151.0585(0.1619, 0.581)14690.25690.4078(0.2361, 0.2778)Post860.87351.1195(0.6369, 1.1101)14450.80561.0444(0.7518, 0.8595)Primary Care OutpatientPre-1590.55550.6957(0.4473, 0.6636)25410.41290.4029(0.3972, 0.4285)Post1591.37361.0466(1.2109, 1.5362)25901.21590.8605(1.1827, 1.249)Specialty Care OutpatientPre-1610.47330.6338(0.3753, 0.5712)26720.38830.5745(0.3665, 0.4101)Post1611.23091.362(1.0205, 1.4413)26350.99881.1018(0.9567, 1.0409)TotalPre-1721.49831.2403(1.313, 1.6837)28511.0920.8239(1.0618, 1.1223)Post1734.39823.2826(3.9091, 4.8874)28703.39852.3366(3.313, 3.484)^1^ Number of patients with at least one visit in the 24 months prior to enrollment and at least one visit in the 24 months following enrollment

Over the 2-year (8 quarter) period following enrollment, COPE enrollees showed a modest statistically significant additional 2.5% quarterly increase compared to control patients, in total utilization of healthcare services (*p* = 0.0008; see Table [4](#Tab4){ref-type="table"}). This increased utilization is primarily attributable to an additional: 3.2% increase in primary care outpatient visits (*p* = 0.024) and 6.3% increase in use of counseling/behavioral services (*p* = 0.0126). We also found a 9.0% increase in pharmacy utilization (*p* \<  0.0001) relative to control patients. We found no statistically significant change in utilization of inpatient, emergency room, specialty outpatient, dental, laboratory, radiology, or community encounter services among COPE participants versus control. Table 4Percent Change in Trend of Average Healthcare Visits per Quarter by Type of Clinic Visited; 8 Quarters Pre- & Post-InterventionVariableEstimate \[1\]95% CI*p*-value**Community Encounters** Non-COPE patient utilization trend, pre-intervention0.9577(0.9442, 0.9715)\<  0.0001 Difference, COPE versus non-COPE patient utilization trend, pre-intervention0.9975(0.9711, 1.0246)0.8546 Difference, pre−/post-intervention utilization trend, non-COPE patients1.0302(1.0029, 1.0583)0.0301 Difference, pre−/post-intervention utilization trend, COPE versus non-COPE patients0.9960(0.9462, 1.0484)0.8791**Counseling/Behavior** Non-COPE patient utilization trend, pre-intervention1.0512(1.0417, 1.0609)\<  0.0001 Difference, COPE versus non-COPE patient utilization trend, pre-intervention0.9455(0.921, 0.9707)\<  0.0001 Difference, pre−/post-intervention utilization trend, non-COPE patients0.9171(0.9027, 0.9316)\<  0.0001 Difference, pre−/post-intervention utilization trend, COPE versus non-COPE patients1.0630(1.0132, 1.1153)0.0126**Dental** Non-COPE patient utilization trend, pre-intervention1.0295(1.0209, 1.0381)\<  0.0001 Difference, COPE versus non-COPE patient utilization trend, pre-intervention0.9836(0.9444, 1.0243)0.4236 Difference, pre−/post-intervention utilization trend, non-COPE patients0.9690(0.9552, 0.9829)\<  0.0001 Difference, pre−/post-intervention utilization trend, COPE versus non-COPE patients1.0410(0.9701, 1.1172)0.2645**Emergency** Non-COPE patient utilization trend, pre-intervention0.9834(0.9777, 0.9892)\<  0.0001 Difference, COPE versus non-COPE patient utilization trend, pre-intervention0.9832(0.9623, 1.0045)0.1211 Difference, pre−/post-intervention utilization trend, non-COPE patients0.9802(0.9698, 0.9907)0.0003 Difference, pre−/post-intervention utilization trend, COPE versus non-COPE patients1.0073(0.9669, 1.0493)0.7290**Inpatient** Non-COPE patient utilization trend, pre-intervention1.0185(1.012, 1.0251)\<  0.0001 Difference, COPE versus non-COPE patient utilization trend, pre-intervention0.9804(0.9564, 1.0051)0.1186 Difference, pre−/post-intervention utilization trend, non-COPE patients0.9856(0.9748, 0.9966)0.0102 Difference, pre−/post-intervention utilization trend, COPE versus non-COPE patients1.0249(0.9808, 1.071)0.2734**Primary Care Outpatient** Non-COPE patient utilization trend, pre-intervention1.0241(1.0199, 1.0283)\<  0.0001 Difference, COPE versus non-COPE patient utilization trend, pre-intervention0.9806(0.9654, 0.996)0.0137 Difference, pre−/post-intervention utilization trend, non-COPE patients0.9756(0.9687, 0.9825)\<  0.0001 Difference, pre−/post-intervention utilization trend, COPE versus non-COPE patients1.0319(1.0041, 1.0605)0.0243**Specialty Care Outpatient** Non-COPE patient utilization trend, pre-intervention1.0179(1.0136, 1.0222)\<  0.0001 Difference, COPE versus non-COPE patient utilization trend, pre-intervention1.0028(0.987, 1.0188)0.7333 Difference, pre−/post-intervention utilization trend, non-COPE patients0.9701(0.9629, 0.9774)\<  0.0001 Difference, pre−/post-intervention utilization trend, COPE versus non-COPE patients1.0040(0.9763, 1.0325)0.7807**Laboratory** Non-COPE patient utilization trend, pre-intervention1.2005(1.1916, 1.2094)\<  0.0001 Difference, COPE versus non-COPE patient utilization trend, pre-intervention0.9806(0.9543, 1.0077)0.1602 Difference, pre−/post-intervention utilization trend, non-COPE patients0.8008(0.792, 0.8098)\<  0.0001 Difference, pre−/post-intervention utilization trend, COPE versus non-COPE patients1.0218(0.9799, 1.0655)0.3122**Pharmacy** Non-COPE patient utilization trend, pre-intervention1.1347(1.1282, 1.1413)\<  0.0001 Difference, COPE versus non-COPE patient utilization trend, pre-intervention0.9245(0.9067, 0.9427)\<  0.0001 Difference, pre−/post-intervention utilization trend, non-COPE patients0.8073(0.7996, 0.8151)\<  0.0001 Difference, pre−/post-intervention utilization trend, COPE versus non-COPE patients1.0901(1.0533, 1.1282)\<  0.0001**Radiology** Non-COPE patient utilization trend, pre-intervention1.0209(1.0009, 1.0412)0.0409 Difference, COPE versus non-COPE patient utilization trend, pre-intervention1.0086(0.9341, 1.0889)0.8272 Difference, pre−/post-intervention utilization trend, non-COPE patients0.9872(0.9548, 1.0207)0.4500 Difference, pre−/post-intervention utilization trend, COPE versus non-COPE patients1.0136(0.8948, 1.148)0.8321**Total 1 (including laboratory, pharmacy & radiology)** Non-COPE patient utilization trend, pre-intervention1.0104(1.0081, 1.0127)\<  0.0001 Difference, COPE versus non-COPE patient utilization trend, pre-intervention0.9778(0.97, 0.9856)\<  0.0001 Difference, pre−/post-intervention utilization trend, non-COPE patients0.9830(0.9791, 0.9868)\<  0.0001 Difference, pre−/post-intervention utilization trend, COPE versus non-COPE patients1.0249(1.0103, 1.0398)0.0008**Total 2 (excluding laboratory, pharmacy & radiology)** Non-COPE patient utilization trend, pre-intervention1.0120(1.0097, 1.0144)\<  0.0001 Difference, COPE versus non-COPE patient utilization trend, pre-intervention0.9834(0.9751, 0.9917)0.0001 Difference, pre−/post-intervention utilization trend, non-COPE patients0.9812(0.9773, 0.9851)\<  0.0001 Difference, pre−/post-intervention utilization trend, COPE versus non-COPE patients1.0205(1.0052, 1.036)0.0086\[1\] The regression was performed as generalized linear mixed regression model for count outcomes, assuming a Poisson distribution for the outcome variable using a log-link. The regression results presented here are the exponentiated values of the specified coefficients to be directly interpretable as the percent change in utilization relative to enrollment in COPE

Discussion {#Sec10}
==========

This study describes the impact on healthcare utilization of a programmatic clinical intervention to improve chronic disease management among individuals working with a CHR on Navajo Nation. The intervention increased the frequency with which COPE patients use NAIHS healthcare services by a modest but statistically significant amount. The effects were found in primary outpatient care, counseling and behavioral services, and pharmacy visits. The intervention has also resulted in a significant improvement in glycemic and lipid control 2 years following patient enrollment in the intervention \[[@CR15]\].

Previous studies evaluating the impact of CHW interventions on healthcare utilization among individuals living with diabetes have been equivocal \[[@CR19]--[@CR21]\], likely due to the heterogeneity of CHW interventions themselves. Thus, the question of **how** the COPE intervention resulted in greater healthcare utilization has relevance for generalizability to other CHW programs. We believe COPE's effectiveness reflects the socio-ecological approach to program design. At the patient level, we have described how patient self-efficacy is strengthened through emotional support, health coaching, and navigation support from CHRs to access care such as appointments and medication refills \[[@CR22]\]. At the provider level, we have described how the intervention enhances CHRs' ability to deliver standardized, evidence-based, culturally-tailored outreach to their patients and communicate more effectively with clinic providers about patient issues \[[@CR23]\]. At the system level, we have demonstrated that the intervention strengthens community-clinic linkages, validating CHRs as members of the care team and increasing care coordination among clinic providers and CHRs \[[@CR24]\]. These facets of the COPE intervention are collectively designed to enhance the role of CHRs as liaisons between the patient and their providers and to empower patients to engage in healthcare services. Both systems-level coordination and patient coaching emphasize primary care and self-management strategies over acute care, such as emergency room visits and hospitalizations. We speculate that both improved clinical outcomes and increased utilization of healthcare services have resulted from increased coordination and communication between CHRs and providers, as well as greater patient self-efficacy and motivation to actively seek healthcare.

This study of utilization leaves an important question outstanding: exactly what types of healthcare did they utilize? We have previously reported that we did not observe a significant difference in "clinical monitoring," defined as HbA1c, LDL, and SBP measurements at least once in the past 12 months \[[@CR15]\]. Nonetheless, it would be informative to assess adherence to American Diabetes Association standards of care \[[@CR25]\]. We will examine that in a second paper based on the use of CPT codes, which will allow us to capture more nuance about utilization patterns. Using both measures provides a better picture of utilization: the increased frequency of visits is robust, since it is subject to relatively little measurement error, but somewhat crude: two primary care clinic visits are "equal" regardless of procedures performed during that visit. Conversely, although code-based reimbursement potentially allows us to compare and aggregate different types of utilization, it may be subject to more measurement error.

Study results should take into consideration that we included only COPE participants who received services at one of the participating sites during study period, relying on availability of routine medical records. Thus, findings may not be representative of other COPE patients who were not identified in the dataset, such as patients who received services elsewhere or not at all. Also, misclassification in diagnoses for specific health conditions as depression and alcohol abuse might affect the main results.

There are several limitations in the design of prospective cohort studies with matched controls. Identifying the study cohort is usually based on diagnostic criteria; in our case, we relied on CHRs to identify which individuals were enrolled in COPE Program. The central problem inherent in such studies is the selection of a comparable control group. The ideal control group would be a random sample from the same general population as the study cohort. We achieved this goal because our non-COPE controls were selected from the same population as the COPE patients. Although we matched non-COPE controls to COPE patients using socio-demographic and clinical characteristics, it was impossible to match for all baseline characteristics due to missing data and characteristics that were not recorded in health records. However, we were able to match more multiple non-COPE controls to each COPE patient to improve the statistical power of our study.

This study did not measure the differences in utilization of CHR services, which could not be collected using RPMS data. While outside the scope of this study, an audit of CHR patient encounter forms demonstrated that home visits (including travel time) to COPE participants versus non-participants took 7 minutes longer on average (35 versus 28 min). Given CHRs also visited COPE participants at least monthly, we estimate CHRs dedicated an additional 3.9 h per year for each COPE participant compared to other CHR clients. CHRs have provided feedback that COPE has contributed to a culture shift toward value-based care, with greater emphasis on clinical monitoring and health education. It is also likely that other CHR clients have benefited from the intervention in a less intensive manner, given that CHRs used flipcharts and behavior change skills as needed with all of their clients. Thus, our study might underestimate the impact of COPE since it attributes no intervention effect to non-COPE patients. Furthermore, to the extent that control patients are affected by, and in the same way as, COPE patients (e.g., increased frequency of use), our study will be less likely to find a statistically significant difference in post-intervention utilization because the difference will be smaller than if there was no COPE effect on controls.

Conclusion {#Sec11}
==========

Our findings suggest that CHR outreach to individuals living with diabetes may increase patient utilization of outpatient healthcare services, without an increase in hospitalization or emergency room visits. We conclude that community health workers -- when integrated with the clinic-based team -- may be effective in increasing patient engagement with primary care services.
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**Additional file 1.** Technical Appendix. Technical Appendix Table 1. Percent Change in Trend of Average Healthcare Visit per Quarter by Type of Clinic Visited; 8 Quarters Pre- & Post-Intervention; Complete Model Results \[1\].

AI/AN

:   American Indian / Alaska Native

CHR

:   Community Health Representative

CHW

:   Community Health Worker

COPE

:   Community Outreach and Patient Empowerment

DM

:   Diabetes mellitus

HbA1c

:   Glycosylated hemoglobin

ICD-10

:   International Statistical Classification of Diseases and Related Health Problems, 10th edition

IHS

:   Indian Health Services

mm Hg

:   millimeters of mercury

NAIHS

:   Navajo Area Indian Health Services

pppq

:   Per patient per quarter

RPMS

:   Resource and patient management system
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